UHC Ignoring Subpoena In Testosterone MDL, Endo Says
UnitedHealthcare should hand over subpoenaed information about its dealings in testosterone replacement drugs if it wants to become part of a proposed class of insurers and third-party payors accusing drug companies...To view the full article, register now.
Already a subscriber? Click here to view full article